ES2344356T3 - Composicion farmaceutica que comprende drospirenona y etinilestradiol. - Google Patents

Composicion farmaceutica que comprende drospirenona y etinilestradiol. Download PDF

Info

Publication number
ES2344356T3
ES2344356T3 ES05777862T ES05777862T ES2344356T3 ES 2344356 T3 ES2344356 T3 ES 2344356T3 ES 05777862 T ES05777862 T ES 05777862T ES 05777862 T ES05777862 T ES 05777862T ES 2344356 T3 ES2344356 T3 ES 2344356T3
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
ethylestradiol
composition including
drospirenone
including drospirenone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES05777862T
Other languages
English (en)
Inventor
Carlos Ariel Sandrone
Jose Mario Sakson
Basaistegui Maria Del Carmen Cajarville
Pomi Jose Daniel Larrosa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Liconsa SA
Original Assignee
Laboratorios Liconsa SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2344356(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Liconsa SA filed Critical Laboratorios Liconsa SA
Application granted granted Critical
Publication of ES2344356T3 publication Critical patent/ES2344356T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composición farmacéutica que comprende drospirenona y etinilestradiol en forma amorfa, adsorbidos sobre un soporte sólido terapéuticamente inerte, en combinación con excipientes farmacéuticamente aceptables, caracterizada porque la composición comprende cantidades medibles del disolvente volátil cloruro de metileno.
ES05777862T 2004-08-09 2005-08-02 Composicion farmaceutica que comprende drospirenona y etinilestradiol. Active ES2344356T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04103837A EP1625849A1 (en) 2004-08-09 2004-08-09 Pharmaceutical composition comprising drospirenone and ethynylestradiol

Publications (1)

Publication Number Publication Date
ES2344356T3 true ES2344356T3 (es) 2010-08-25

Family

ID=34929434

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05777862T Active ES2344356T3 (es) 2004-08-09 2005-08-02 Composicion farmaceutica que comprende drospirenona y etinilestradiol.

Country Status (20)

Country Link
US (1) US20090227546A1 (es)
EP (2) EP1625849A1 (es)
JP (1) JP2008509195A (es)
KR (1) KR20070045247A (es)
CN (1) CN101022811B (es)
AR (1) AR045576A1 (es)
AT (1) ATE464053T1 (es)
AU (1) AU2005271206B2 (es)
BR (1) BRPI0513938B8 (es)
CA (1) CA2574997A1 (es)
DE (1) DE602005020694D1 (es)
ES (1) ES2344356T3 (es)
HK (1) HK1109579A1 (es)
IL (1) IL180899A0 (es)
MA (1) MA28844B1 (es)
NO (1) NO20071297L (es)
RU (1) RU2007108666A (es)
UA (1) UA87513C2 (es)
WO (1) WO2006015956A1 (es)
ZA (1) ZA200702038B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2531929T3 (es) * 2006-12-20 2015-03-20 Teva Women's Health, Inc. Formas de dosificación solidas que se disgregan en la boca que comprenden progestina y métodos para hacer y usar las mismas
HUP0700826A3 (en) * 2007-12-20 2010-03-29 Richter Gedeon Nyrt Coated tablet containing drospirenone and process for producing the same
DE102008037025C5 (de) 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
WO2010114405A2 (en) * 2009-04-01 2010-10-07 Bial - Portela & Ca., S.A. Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
CN105878242A (zh) 2009-04-01 2016-08-24 巴尔-波特拉及康邦亚股份有限公司 包括硝基儿茶酚衍生物的药物制剂及其制备方法
US10849857B2 (en) * 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en) * 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
CN102274235B (zh) * 2011-06-27 2013-03-13 潍坊中狮制药有限公司 一种新的避孕药物组合及制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
FR2722984B1 (fr) * 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US6027747A (en) * 1997-11-11 2000-02-22 Terracol; Didier Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions
MXPA02002043A (es) * 1999-08-31 2003-08-20 Schering Ag Composicion farmaceutica de etinilestradiol y drospirenona para el uso como anticonceptivo.
EP2044941A1 (en) * 1999-08-31 2009-04-08 Bayer Schering Pharma AG Multiple-phase formulation of drospirenone and estradiol as a contraceptive
DE60114467T2 (de) * 2000-12-14 2006-07-20 Ortho-Mcneil Pharmaceutical, Inc. Zubereitungen enthaltend ein steroidhormon und ein stabilisierungsmittel in nicht-kristalliner form
EP1216712A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Cyclodextrin-drospirenone inclusion complexes

Also Published As

Publication number Publication date
IL180899A0 (en) 2007-07-04
AU2005271206A1 (en) 2006-02-16
JP2008509195A (ja) 2008-03-27
CA2574997A1 (en) 2006-02-16
EP1848441B1 (en) 2010-04-14
CN101022811A (zh) 2007-08-22
NO20071297L (no) 2007-05-02
WO2006015956A1 (en) 2006-02-16
ZA200702038B (en) 2008-08-27
UA87513C2 (ru) 2009-07-27
AU2005271206B2 (en) 2009-11-26
DE602005020694D1 (de) 2010-05-27
MA28844B1 (fr) 2007-09-03
BRPI0513938B1 (pt) 2018-09-25
AR045576A1 (es) 2005-11-02
RU2007108666A (ru) 2008-09-20
EP1848441A1 (en) 2007-10-31
HK1109579A1 (en) 2008-06-13
KR20070045247A (ko) 2007-05-02
BRPI0513938B8 (pt) 2021-05-25
ATE464053T1 (de) 2010-04-15
EP1625849A1 (en) 2006-02-15
US20090227546A1 (en) 2009-09-10
CN101022811B (zh) 2010-09-15
BRPI0513938A (pt) 2008-05-20

Similar Documents

Publication Publication Date Title
ES2344356T3 (es) Composicion farmaceutica que comprende drospirenona y etinilestradiol.
NO20076613L (no) Farmasoytiske formuleringer og anvendelse derav
ATE540680T1 (de) Pharmazeutische aripiprazol-zusammensetzungen
WO2007070632A3 (en) Abuse resistant transmucosal drug delivery device
MX2010004323A (es) Formas de dosificacion oral que comprenden acetato de licarbazepina.
WO2011049706A8 (en) Orally transformable tablets
CL2011000101A1 (es) Compuestos derivados de piridazina sustituida; inhibidores de la señalizacion hedgehog y smo; composicion farmaceutica; y uso para el tratamiento de trastornos o sindromes asociados con enfermedades hiperproliferativas.
RS52651B (en) PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENS AND / OR ESTROGENS AND 5-METHYL- (6S) -TETRAHYDROPHOLATE
EP1789075A4 (en) ABSORPTION ENHANCER FOR DRUG ADMINISTRATION
MX2013004137A (es) Composicion farmaceutica.
MX2007007613A (es) Formulaciones farmaceuticas.
WO2009063222A3 (en) Solid compositions
WO2006023644A3 (en) Transdermal drug delivery device with translucent protective film
IL188744A0 (en) High drug load formulations and dosage forms
NO20062198L (no) Bradykinin B1 reseptorantagonister
WO2006131806A3 (en) Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release
WO2006041878A3 (en) Primary examiner
ITTO20040390A1 (it) Composizione, in particolare per uso farmaceutico, ad azione antiossidante, antinfiammatoria ed immunostimolante.
CY1114933T1 (el) Στερεες φαρμακευτικες συνθεσεις σταθερης δοσης περιεχουσες ιρβεσαρτανη και αμλοδιπινη, η παρασκευη τους και η θεραπευτικη εφαρμογη τους
ECSP088555A (es) Composiciones farmacéuticas
WO2010052466A8 (en) Pharmaceutical aerosol composition
NO20091467L (no) Farmasoytiske formuleringer som omfatter klopidogrel
SM200500011A (it) Una composizione farmaceutica antimicobatterica
CL2008000965A1 (es) Composicion farmaceutica que comprende un agente antiinflamatorio no esteroideo y un analgesico opiaceo, y su uso para el tratamiento del dolor.
NO20026244D0 (no) Neurobeskyttende 7-beta-hydroksysteroider